Who
Kathy Ordonez
Director
Company insider
Files Form 4 as: Chief Commercial Officer, Pacific Biosciences of California; Director, Quidel Corp /de/; SVP, Diagnostic Solutions, Quest Diagnostics; CEO and Director, Celera; Senior Vice President, Applera.
In numbers
- Trades disclosed
- 322
- Buys
- 2
- Sells
- 14
- Bought
- $100K
- Sold
- $11.4M
- Companies
- 5
- Companies where not an officer
- 1
- First trade
- 30 Jan 2007
- Last trade
- 3 Jun 2026
- Last filed
- 4 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Jun 2026filed 4 Jun 2026 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —223,492 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —223,492 at $0.00 | filing |
| 4 Jun 2025filed 6 Jun 2025 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —32,179 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code A | —22,821 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code M | —324,515 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code M | —37,106 at $0.00 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code M | $941K324,515 at $2.90 | filing |
| 15 Mar 2024filed 19 Mar 2024 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code M | $98K37,106 at $2.63 | filing |
| 24 May 2023filed 26 May 2023 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —25,775 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —63,015 at $0.00 | filing |
| 16 Feb 2022filed 17 Feb 2022 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Sold | $38K3,280 at $11.50 | filing |
| 16 Jun 2021filed 21 Jun 2021 | PACB Pacific Biosciences of Californiaoption or derivative · Life-science tools | SEC FORM 4 Code A | —12,885 at $0.00 | filing |
| 18 May 2021filed 20 May 2021 | Quidel Corp /de/option or derivative | SEC FORM 4 Code A | —1,624 at $0.00 | filing |
| 18 May 2021filed 20 May 2021 | Quidel Corp /de/option or derivative | SEC FORM 4 Code A | —427 at $0.00 | filing |
| 18 May 2021filed 20 May 2021 | Quidel Corp /de/option or derivative | SEC FORM 4 Code A | —42 at $0.00 | filing |
| 12 May 2021filed 14 May 2021 | Quidel Corp /de/ | SEC FORM 4 Code M | —1,040 at $0.00 | filing |
| 12 May 2021filed 14 May 2021 | Quidel Corp /de/option or derivative | SEC FORM 4 Code M | —1,040 at $0.00 | filing |
| 16 Feb 2021filed 18 Feb 2021 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code M | $244K35,000 at $6.98 | filing |
| 16 Feb 2021filed 18 Feb 2021 | PACB Pacific Biosciences of CaliforniaLife-science tools | SEC FORM 4 Code M | $145K25,000 at $5.79 | filing |
News
No headline names them, or the companies they trade most, lately.